Posts

Showing posts from January 16, 2019

Barrie R. Cassileth

Image
Barrie R. Cassileth is an American researcher of complementary and alternative medicine, and has published extensively on alternative cancer treatments. She founded the Integrative Medicine Service at the Memorial Sloan-Kettering Cancer Center, and holds the Laurance S. Rockefeller Chair in Integrative Medicine. [1] She also founded the Society for Integrative Oncology, which publishes a medical journal. Cassileth, born Barrie Rabinowitz, obtained her PhD in medical sociology from the University of Pennsylvania in 1978. [2] [3] Papers Vickers, Andrew J.; Kuo, Joyce; Cassileth, Barrie R. (2006). "Unconventional Anticancer Agents: A Systematic Review of Clinical Trials". Journal of Clinical Oncology . 24 (1): 136–40. doi:10.1200/JCO.2005.03.8406. PMC  1472241 . PMID 16382123. Archived from the original (w) on 2009-02-26 . Retrieved 2008-07-19 . .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""

Burzynski Clinic

The Burzynski Clinic is a controversial clinic offering an unproven cancer treatment. It was founded in 1976 and is located in Texas, United States. It is best known for the controversial "antineoplaston therapy" devised by the clinic's founder Stanislaw Burzynski in the 1970s. Antineoplaston are a group of peptides, peptide derivatives, and mixtures that Burzynski named to use in his "cancer treatment". There is no accepted scientific evidence of benefit from antineoplaston combinations for various diseases. The clinic has been the focus of criticism primarily due to the way its antineoplaston therapy is promoted, the costs for people with cancer participating in "trials" of antineoplastons, problems with the way these trials are run, and legal cases brought as a result of the sale of the therapy without state board approval. Contents 1 Stanislaw Burzynski 2 Antineoplaston therapy 2.1 Clinical trials 2.2 Efficacy 2.3